Fairfield Bush & CO. continued to hold its position in shares of Express Scripts Holding Company (NASDAQ:ESRX) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 3,280 shares of the company’s stock at the end of the 2nd quarter. Fairfield Bush & CO.’s holdings in Express Scripts Holding were worth $209,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Burt Wealth Advisors boosted its stake in shares of Express Scripts Holding by 11.4% during the 2nd quarter. Burt Wealth Advisors now owns 1,696 shares of the company’s stock worth $108,000 after purchasing an additional 174 shares during the last quarter. CKW Financial Group boosted its stake in shares of Express Scripts Holding by 20.0% during the 2nd quarter. CKW Financial Group now owns 1,800 shares of the company’s stock worth $115,000 after purchasing an additional 300 shares during the last quarter. IHT Wealth Management LLC boosted its stake in shares of Express Scripts Holding by 8.1% during the 1st quarter. IHT Wealth Management LLC now owns 1,944 shares of the company’s stock worth $128,000 after purchasing an additional 145 shares during the last quarter. First Personal Financial Services boosted its stake in shares of Express Scripts Holding by 199.1% during the 2nd quarter. First Personal Financial Services now owns 2,103 shares of the company’s stock worth $134,000 after purchasing an additional 1,400 shares during the last quarter. Finally, FNY Partners Fund LP acquired a new stake in shares of Express Scripts Holding during the 1st quarter worth about $138,000. 88.69% of the stock is currently owned by institutional investors.

COPYRIGHT VIOLATION NOTICE: This piece of content was published by Watch List News and is the property of of Watch List News. If you are reading this piece of content on another site, it was illegally copied and republished in violation of U.S. & international copyright and trademark laws. The legal version of this piece of content can be accessed at https://www.watchlistnews.com/express-scripts-holding-company-esrx-stake-maintained-by-fairfield-bush-co/1641036.html.

In other Express Scripts Holding news, Director Woodrow A. Myers, Jr. sold 3,900 shares of the company’s stock in a transaction that occurred on Monday, September 11th. The stock was sold at an average price of $63.93, for a total transaction of $249,327.00. Following the completion of the sale, the director now owns 11,500 shares of the company’s stock, valued at $735,195. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Everett Neville sold 1,163 shares of the company’s stock in a transaction that occurred on Wednesday, August 23rd. The stock was sold at an average price of $61.48, for a total value of $71,501.24. Following the sale, the vice president now directly owns 18,232 shares of the company’s stock, valued at approximately $1,120,903.36. The disclosure for this sale can be found here. Insiders have sold 5,641 shares of company stock valued at $357,317 in the last ninety days. Company insiders own 0.68% of the company’s stock.

Shares of Express Scripts Holding Company (NASDAQ:ESRX) opened at 57.77 on Thursday. The stock has a market cap of $33.37 billion, a price-to-earnings ratio of 10.03 and a beta of 0.88. The stock’s 50 day moving average is $61.54 and its 200-day moving average is $62.24. Express Scripts Holding Company has a 1-year low of $55.80 and a 1-year high of $77.50.

Express Scripts Holding (NASDAQ:ESRX) last announced its quarterly earnings results on Tuesday, July 25th. The company reported $1.73 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.71 by $0.02. The business had revenue of $25.35 billion during the quarter, compared to analysts’ expectations of $25.52 billion. Express Scripts Holding had a return on equity of 25.58% and a net margin of 3.50%. The firm’s quarterly revenue was up .5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.57 EPS. On average, analysts anticipate that Express Scripts Holding Company will post $6.99 EPS for the current year.

ESRX has been the topic of several research analyst reports. Zacks Investment Research raised shares of Express Scripts Holding from a “hold” rating to a “buy” rating and set a $64.00 target price on the stock in a research report on Monday. Raymond James Financial, Inc. reissued an “underperform” rating on shares of Express Scripts Holding in a research report on Monday, October 9th. UBS AG cut shares of Express Scripts Holding from a “market perform” rating to an “underperform” rating in a research report on Monday, October 9th. ValuEngine raised shares of Express Scripts Holding from a “hold” rating to a “buy” rating in a research report on Monday, October 2nd. Finally, Royal Bank Of Canada initiated coverage on shares of Express Scripts Holding in a research report on Tuesday, September 19th. They issued a “sector perform” rating and a $68.00 target price on the stock. Six investment analysts have rated the stock with a sell rating, eleven have given a hold rating, seven have given a buy rating and one has given a strong buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of $69.09.

About Express Scripts Holding

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Institutional Ownership by Quarter for Express Scripts Holding (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with Analyst Ratings Network's FREE daily email newsletter.